SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
17-May-22 5:12 PM View: | Checkmate Pharmaceuticals, ... (CMPI) | 16-May-22 | Sale | 95,800 | $10.45 | $1,001,100.00 | (4%) 2.25M to 2.16M | |
17-May-22 5:12 PM View: | Checkmate Pharmaceuticals, ... (CMPI) | 13-May-22 | Private Sale | 35,850 | $10.45 | $374,464.00 | (2%) 2.29M to 2.25M | |
12-May-22 8:47 PM View: | Checkmate Pharmaceuticals, ... (CMPI) | 12-May-22 | Sale | 124,525 | $10.39 | $1,294,310.00 | (5%) 2.41M to 2.29M | |
12-May-22 8:47 PM View: | Checkmate Pharmaceuticals, ... (CMPI) | 11-May-22 | Sale | 17,700 | $10.38 | $183,641.00 | (< 1%) 2.43M to 2.41M | |
12-May-22 8:47 PM View: | Checkmate Pharmaceuticals, ... (CMPI) | 10-May-22 | Private Sale | 18,676 | $10.38 | $193,870.00 | (< 1%) 2.45M to 2.43M | |
09-May-22 6:58 PM View: | Checkmate Pharmaceuticals, ... (CMPI) | 09-May-22 | Sale | 17,600 | $10.37 | $182,582.00 | (< 1%) 2.47M to 2.45M | |
09-May-22 6:58 PM View: | Checkmate Pharmaceuticals, ... (CMPI) | 06-May-22 | Sale | 48,334 | $10.37 | $501,233.00 | (2%) 2.51M to 2.47M | |
09-May-22 6:58 PM View: | Checkmate Pharmaceuticals, ... (CMPI) | 05-May-22 | Private Sale | 20,743 | $10.37 | $215,105.00 | (< 1%) 2.54M to 2.51M | |
04-May-22 7:30 PM View: | Checkmate Pharmaceuticals, ... (CMPI) | 04-May-22 | Sale | 37,500 | $10.37 | $388,924.00 | (1%) 2.57M to 2.54M | |
04-May-22 7:30 PM View: | Checkmate Pharmaceuticals, ... (CMPI) | 03-May-22 | Sale | 79,475 | $10.37 | $824,434.00 | (3%) 2.65M to 2.57M | |
04-May-22 7:30 PM View: | Checkmate Pharmaceuticals, ... (CMPI) | 02-May-22 | Private Sale | 153,700 | $10.38 | $1,595,970.00 | (5%) 2.81M to 2.65M | |
29-Apr-22 5:50 PM View: | Checkmate Pharmaceuticals, ... (CMPI) | 29-Apr-22 | Sale | 69,230 | $10.38 | $718,663.00 | (2%) 2.88M to 2.81M | |
29-Apr-22 5:50 PM View: | Checkmate Pharmaceuticals, ... (CMPI) | 28-Apr-22 | Sale | 73,400 | $10.38 | $761,936.00 | (2%) 2.95M to 2.88M | |
29-Apr-22 5:50 PM View: | Checkmate Pharmaceuticals, ... (CMPI) | 27-Apr-22 | Private Sale | 47,396 | $10.38 | $491,980.00 | (2%) 3.0M to 2.95M | |
26-Apr-22 6:40 PM View: | Checkmate Pharmaceuticals, ... (CMPI) | 26-Apr-22 | Sale | 64,683 | $10.38 | $671,558.00 | (2%) 3.06M to 3.0M | |
26-Apr-22 6:40 PM View: | Checkmate Pharmaceuticals, ... (CMPI) | 25-Apr-22 | Sale | 27,668 | $10.39 | $287,404.00 | (< 1%) 3.09M to 3.06M | |
26-Apr-22 6:40 PM View: | Checkmate Pharmaceuticals, ... (CMPI) | 22-Apr-22 | Private Sale | 37,430 | $10.39 | $388,834.00 | (1%) 3.13M to 3.09M | |
21-Apr-22 8:54 PM View: | Checkmate Pharmaceuticals, ... (CMPI) | 21-Apr-22 | Sale | 62,200 | $10.38 | $645,866.00 | (2%) 3.19M to 3.13M | |
21-Apr-22 8:54 PM View: | Checkmate Pharmaceuticals, ... (CMPI) | 20-Apr-22 | Sale | 85,611 | $10.39 | $889,387.00 | (3%) 3.27M to 3.19M | |
21-Apr-22 8:54 PM View: | Checkmate Pharmaceuticals, ... (CMPI) | 19-Apr-22 | Private Sale | 399,923 | $10.42 | $4,165,240.00 | (11%) 3.67M to 3.27M | |
29-Apr-21 6:44 PM View: | Ipi Legacy Liquidation Co (IMPLQ) | 27-Apr-21 | Conversion | 2,309,790 | -- | -- | 100% 0 to 2.31M | |
29-Apr-21 6:44 PM View: | Ipi Legacy Liquidation Co (IMPLQ) | 27-Apr-21 | Market Purchase | 450,000 | $15.00 | $6,750,000.00 | 19% 2.31M to 2.76M | |
12-Aug-20 9:00 PM View: | Checkmate Pharmaceuticals, ... (CMPI) | 11-Aug-20 | Conversion | 3,473,370 | -- | -- | 100% 0 to 3.47M | |
12-Aug-20 9:00 PM View: | Checkmate Pharmaceuticals, ... (CMPI) | 11-Aug-20 | Purchase | 200,000 | $15.00 | $3,000,000.00 | 6% 3.47M to 3.67M | |
06-Jul-20 7:00 PM View: | Akero Therapeutics, Inc. (AKRO) | 06-Jul-20 | Sale | 4,603 | $33.83 | $155,721.00 | (< 1%) 3.04M to 3.03M | |
06-Jul-20 7:00 PM View: | Akero Therapeutics, Inc. (AKRO) | 02-Jul-20 | Sale | 3,800 | $33.63 | $127,805.00 | (< 1%) 3.04M to 3.04M | |
06-Jul-20 7:00 PM View: | Akero Therapeutics, Inc. (AKRO) | 01-Jul-20 | Sale | 108,064 | $34.45 | $3,723,010.00 | (3%) 3.15M to 3.04M | |
06-Mar-20 5:23 PM View: | Akero Therapeutics, Inc. (AKRO) | 06-Mar-20 | Sale | 1,800 | $23.79 | $42,830.80 | (< 1%) 3.15M to 3.15M | |
06-Mar-20 5:23 PM View: | Akero Therapeutics, Inc. (AKRO) | 05-Mar-20 | Sale | 8,500 | $23.53 | $200,011.00 | (< 1%) 3.16M to 3.15M | |
06-Mar-20 5:23 PM View: | Akero Therapeutics, Inc. (AKRO) | 04-Mar-20 | Sale | 35,650 | $23.81 | $848,766.00 | (1%) 3.2M to 3.16M | |
03-Mar-20 5:52 PM View: | Akero Therapeutics, Inc. (AKRO) | 03-Mar-20 | Sale | 6,401 | $23.00 | $147,199.00 | (< 1%) 3.2M to 3.2M | |
03-Mar-20 5:52 PM View: | Akero Therapeutics, Inc. (AKRO) | 02-Mar-20 | Sale | 10,297 | $23.06 | $237,459.00 | (< 1%) 3.21M to 3.2M | |
03-Mar-20 5:52 PM View: | Akero Therapeutics, Inc. (AKRO) | 28-Feb-20 | Sale | 5,100 | $21.30 | $108,652.00 | (< 1%) 3.22M to 3.21M | |
27-Feb-20 7:51 PM View: | Akero Therapeutics, Inc. (AKRO) | 27-Feb-20 | Sale | 1,781 | $22.54 | $40,143.70 | (< 1%) 3.23M to 3.23M | |
27-Feb-20 7:51 PM View: | Akero Therapeutics, Inc. (AKRO) | 26-Feb-20 | Sale | 2,523 | $22.44 | $56,615.40 | (< 1%) 3.23M to 3.23M | |
27-Feb-20 7:51 PM View: | Akero Therapeutics, Inc. (AKRO) | 25-Feb-20 | Sale | 1,600 | $23.67 | $37,876.00 | (< 1%) 3.23M to 3.23M | |
12-Feb-20 5:56 PM View: | Akero Therapeutics, Inc. (AKRO) | 12-Feb-20 | Sale | 6 | $27.14 | $162.84 | (< 1%) 3.23M to 3.23M | |
12-Feb-20 5:56 PM View: | Akero Therapeutics, Inc. (AKRO) | 11-Feb-20 | Sale | 2,184 | $27.05 | $59,068.00 | (< 1%) 3.24M to 3.23M | |
12-Feb-20 5:56 PM View: | Akero Therapeutics, Inc. (AKRO) | 10-Feb-20 | Sale | 7,836 | $27.08 | $212,168.00 | (< 1%) 3.23M to 3.23M | |
10-Feb-20 5:47 PM View: | Akero Therapeutics, Inc. (AKRO) | 06-Feb-20 | Sale | 6,102 | $27.03 | $164,955.00 | (< 1%) 3.24M to 3.23M | |
06-Feb-20 4:06 PM View: | Akero Therapeutics, Inc. (AKRO) | 05-Feb-20 | Sale | 28,608 | $25.99 | $743,548.00 | (< 1%) 3.27M to 3.24M | |
06-Feb-20 4:06 PM View: | Akero Therapeutics, Inc. (AKRO) | 04-Feb-20 | Sale | 53,731 | $25.65 | $1,378,180.00 | (2%) 3.32M to 3.27M | |
14-Jan-20 8:58 AM View: | Akero Therapeutics, Inc. (AKRO) | 13-Jan-20 | Sale | 494,000 | $20.23 | $9,993,620.00 | (13%) 3.82M to 3.32M | |
10-Jan-20 4:06 PM View: | Akero Therapeutics, Inc. (AKRO) | 08-Jan-20 | Sale | 15,677 | $19.86 | $311,355.00 | (< 1%) 3.83M to 3.82M | |
08-Jan-20 4:10 PM View: | Akero Therapeutics, Inc. (AKRO) | 07-Jan-20 | Sale | 31,000 | $20.17 | $625,149.00 | (< 1%) 3.86M to 3.83M | |
08-Jan-20 4:10 PM View: | Akero Therapeutics, Inc. (AKRO) | 06-Jan-20 | Sale | 42,221 | $19.64 | $829,381.00 | (1%) 3.91M to 3.86M | |
06-Jan-20 4:07 PM View: | Akero Therapeutics, Inc. (AKRO) | 03-Jan-20 | Sale | 12,498 | $19.30 | $241,214.00 | (< 1%) 3.92M to 3.91M | |
06-Jan-20 4:07 PM View: | Akero Therapeutics, Inc. (AKRO) | 02-Jan-20 | Sale | 23,000 | $19.94 | $458,507.00 | (< 1%) 3.94M to 3.92M | |
03-Jan-20 4:13 PM View: | Akero Therapeutics, Inc. (AKRO) | 31-Dec-19 | Sale | 14,324 | $23.96 | $343,259.00 | (< 1%) 3.95M to 3.94M | |
25-Jun-19 9:20 AM View: | Akero Therapeutics, Inc. (AKRO) | 24-Jun-19 | Conversion Duplicate | 3,704,860 | -- | -- | 100% 0 to 3.7M |